Teva Pharmaceutical Industries Limited (TEVA)

Trade TEVA now with
11/22/2022 8:34:10 AM Teva Says Finalizes Nationwide Opioid Settlement Terms
11/21/2022 7:03:54 AM Teva Appoints Richard Francis As President And CEO, Effective January 1, 2023
11/3/2022 7:13:40 AM Teva Pharmaceutical Industries Limited (TEVA) Has Lowered Its FY22 Revenue Estimate To $14.8 - $15.4 Bln From $15.0 - $15.6 Bln
11/3/2022 7:05:29 AM Teva Q3 GAAP EPS $0.05; Non-GAAP EPS $0.59
10/18/2022 8:06:48 AM Teva Announces Positive Results From 3-Year Study Of AUSTEDO Tablets In Chorea Associated With Huntington's Disease
10/7/2022 8:34:16 AM Teva Reaches Agreement With Attorney General Of Arkansas to Settle State's Price-fixing Claims
9/30/2022 8:07:09 AM Teva Reaches Agreement With Georgia To Settle The State's Price Fixing Claims
9/8/2022 1:50:38 AM Teva Says Studies Show Effectiveness Of AJOVY For Treatment Of Migraine In Patients With Co-morbid Depression
8/29/2022 2:04:15 AM Teva : EC Grants Marketing Authorization For Ranivisio, Biosimilar To Lucentis, For Age-related Macular Degeneration